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ess: mhvargasb@yahoo.Summary One plausible explanation for the worldwide epidemic increase of
asthma prevalence is the hygiene hypothesis, which suggests that better control of
infections shifts the immune response toward an allergic phenotype. However,
studies demonstrating an inverse association between asthma and infectious
diseases are scarce and possess conflicting results. To explore the relationship
between asthma and scarlet fever, an ecological analysis of their national trends was
carried out. Association of both diseases in their annual (1996–2003), seasonal (by
month) and geographic (by state) trends was evaluated using the Spearman’s
correlation coefficient (rS). Results showed a strong inverse association between
asthma and scarlet fever in all settings. Thus, annual incidence rates of both
diseases showed an rS ¼ 0:93 (P ¼ 0:0009). Seasonal patterns showed a higher
proportion of new asthma cases from September to January, while the number of
scarlet fever cases increased from March to June (rS ¼ 0:84, P ¼ 0:0006, 1-month
lag). Among the 32 Mexican states, the higher the incidence of scarlet fever the
lower the incidence of asthma (rS ¼ 0:47, P ¼ 0:007). These results suggest that
Streptococcus pyogenes, the causative agent of scarlet fever, might be one of the
major protagonists of the hygiene hypothesis, a possibility deserving of further
investigation.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
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In recent decades, a notable increment in asthma
prevalence has occurred in many regions of the
world, but to date the cause of this epidemic is
largely unknown.1–3 One of the most plausible
explanations is the hygiene hypothesis, which
suggests that progressive achievements in theed.
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number of people have predisposed these indivi-
duals to the development of an allergic pheno-
type.4 This is supposedly based on the reciprocal
balance between Th1 and Th2 subtypes of T-cells,
conditioning that inadequate stimulation of Th1
responses lead to overproduction of Th2 T-cell-
derived cytokines, which eventually promote the
allergic state.5 Nevertheless, despite its attrac-
tiveness this hypothesis is far from being con-
firmed, and studies demonstrating an inverse
relationship between some infectious agents and
asthma or atopy remains scarce and with conflict-
ing results.6–9 In a previous work, we found that
medical services for asthma varied greatly among
the 32 Mexican states.10 During this study, we
realized that the morbidity rates of nearly all
infectious or parasitic diseases either did not
correlate at all or showed a tendency to correlate
positively with rates of asthma medical services.
The only infectious disease that had a negative
correlation with asthma and thus supported the
hygiene hypothesis was scarlet fever. The more in-
deep analysis of a possible relationship between
asthma and scarlet fever is the basis of the present
report.Methods
In 1995, asthma became a notifiable disease in
Mexico. In the present study, data concerning the
number of new cases or incidence rates of asthma
and scarlet fever in subjects of all ages were
obtained from the website of the Mexican Ministry
of Health’s Direccio´n General de Epidemiologı´a.11
This institution coordinates the registry of 110
diseases, both transmissible and non-transmissible,
for which notification is mandatory by law. From all
health units providing health services in Mexico
(17,138 in the year 2000), those actively involved
in disease notification increased from approxi-
mately 60% in 1995 to 490% in 2001. Each week,
health units register all new cases of notifiable
diseases in an electronic format; this registry is
then centralized in the Direccio´n General de
Epidemiologı´a for analysis and diffusion. Quality
of information is continuously monitored by spe-
cialized staffs who apply corrective measures when
needed. Annual trends from 1996 to 2003 were
evaluated directly through national incidence rates
( 100,000 inhabitants), while seasonal trends (by
month) and geographic distribution (by state) were
evaluated by averaging number of cases or annual
incidence rates, respectively, from the last 5 yearsof the available period. Statistical evaluation was
carried out using the Spearman’s correlation
coefficient (rS), while statistical significance was
set at two-tailed Po0:05.Results
With respect to time trends, data showed that
during the last 8 years asthma incidence rates were
relatively stable and with minor changes, from
239.7 in 1996 to 289.1 in 2003. During this same
period, time trends of scarlet fever showed a strong
negative correlation with respect to asthma, from
15.9 in 1996 to 9.1 in 2003 (Fig. 1A). Correlation
between annual incidences of asthma and scarlet
fever yielded an rS ¼ 0:93 (P ¼ 0:0009).
Regarding seasonal trends, the number of newly
diagnosed asthma cases notably increased from
September to January, while those corresponding
to scarlet fever increased from March to June (Fig.
1B). This inverse pattern had a non-significant
correlation with an rS ¼ 0:38. However, when
data were re-analyzed with a 1-month lag, the
number of scarlet fever cases strongly correlated
with the number of asthma cases occurring 1 month
later (rS ¼ 0:84, P ¼ 0:0006).
Finally, when the geographic relationship be-
tween both diseases was explored in all 32 Mexican
states, it was apparent that asthma incidence
decreased as scarlet fever incidence increased
(Fig. 1C), yielding an rS ¼ 0:47 (P ¼ 0:007).Discussion
Although the so-called hygiene hypothesis is an
attractive explanation for the recent asthma
epidemic, it has not been conclusively demon-
strated to date5 and studies reporting an inverse
association between asthma and an infectious
disease such as measles and hepatitis remain scarce
and with conflicting results.6–9 Likewise, while
some epidemiologic studies have claimed that the
history of BCG vaccination was associated with a
diminished frequency of asthma, others have been
unable to corroborate such an association, and
several prospective studies in asthma patients
receiving BCG vaccine have yielded inconsistent
results.12–14
The present work strongly suggests a link
between scarlet fever and asthma, though the
nature of this association remains to be clarified.
An interesting possibility is that Streptococcus
pyogenes, the causative agent of scarlet fever,
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Figure 1 Inverse associations between scarlet fever and asthma in several settings in Mexico. Panel A shows annual
incidence rates of both diseases in the last 8 years (left), and the corresponding scatter graph (right). Panel B illustrates
seasonal trends (month-by-month) of both diseases after applying a 1-month lag (left), and the corresponding scatter
graph (right). In this latter panel, symbols correspond to average and standard error of 5 years (1999–2003). Panel C
corresponds to the correlation between incidence rates (average, 1999–2003) of scarlet fever and asthma in the 32
Mexican states.
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process. This microorganism colonizes humans
exclusively and can cause a wide range of infec-
tions in skin, throat, or other mucosal surfaces and
deep tissues. More important, however, is that the
prevalence of subjects carrying S. pyogenes in
pharynx may be as high as 20%.15 Thus, in the
present study incidence of scarlet fever might
constitute a surrogate of the carrier-state preva-
lence in general population.
S. pyogenes is a Gram-positive coccus with some
of the most potent superantigens known to date,
such as the streptococcal mitogenic exotoxin
(SMEZ) and the erythrogenic exotoxins A and C
(SPEA and SPEC, respectively).16 Superantigens
cause polyclonal activation of T-cells via their Vb
domain and induce release of a wide array ofcytokines.16,17 Mu¨ller-Alouf et al.18 demonstrated
in peripheral blood mononuclear cells cultures that
such cytokine release could also be produced by
heat-killed streptococci, suggesting that bacteria
themselves may evoke this effect via their cell wall
components. In this latter study, main cytokines
released by SMEZ, SPEA and heat-killed strepto-
cocci were IFN-g (from 600 to 1000-fold the amount
released by non-stimulated cells) and IL-12 (4200-
fold), while the IL-4 increment was negligible.
Thus, at least theoretically S. pyogenes has the
potential to shift the immune status toward a Th1
response. The possible role of bacterial infections
(especially by Gram-positive bacteria) in prevent-
ing the development of asthma is in line with
studies showing that antibiotic use in the first
years of life is accompanied by a higher risk of
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high concentration of muramic acid in mattress
dust is associated with lower prevalence of wheez-
ing in children.21
This possible cause–effect relationship between
scarlet fever, in the strict sense, or the S. pyogenes
carrier state, in the broad sense, and asthma
protection deserves to be fully explored, though
alternative explanations (e.g., that asthma di-
minishes the infectivity or pathogenicity of S.
pyogenes, or that asthma and scarlet fever are
independent diseases related to a third factor)
should also be considered and further investigated.References
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